Click here for Analysts' Upgrades, Downgrades.

Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK ( TheStreet) -- STOCK COMMENTS / EPS CHANGES

Atlas Air Worldwide ( AAWW) numbers boosted at Goldman. Shares of AAWW now seen reaching $59. Estimates also upped, given better freight demand. Neutral rating.

American Express ( AXP) price target boosted at Barclays. AXP price target jumped to $55 from $51. Purchase volumes continue to rebound. Maintain Overweight rating.

Baker Hughes ( BHI) price target raised at Citi to $56 from $49 after strong third-quarter results. Maintain Hold rating.

Baker Hughes ( BHI) numbers raised at UBS. Shares of BHI now seen reaching $52. Estimates also increased, because of higher expected international margins. Neutral rating.

Ball ( BLL) price target raised at Credit Suisse. BLL price target boosted to $69 from $64. 2011 offers quadruple play of growth. Maintain Outperform rating.

Ball ( BLL) price target raised at Credit Suisse to $69 from $64. 2011 offers quadruple play of growth. Maintain Outperform rating.

Cognizant Technology ( CTSH) numbers increased at Goldman. CTSH estimates were raised through 2012. Company is seeing higher sales demand. Neutral rating and new $71 price target.

Discover Financial ( DFS) price target higher at Barclays to $23 from $20. Credit trends pave the way to normalized EPS. Maintain Overweight rating.

Endo Pharmaceuticals ( ENDP) numbers raised at Oppenheimer. Shares of ENDP now seen reaching $42. Estimates also increased, given lower expenses. Outperform rating.

Endo Pharmaceuticals ( ENDP) numbers lowered at Goldman. Shares of ENDP now seen reaching $30. Estimates also cut, given lower sales across the board. Neutral rating.

Estee Lauder ( EL) numbers boosted at Goldman. Shares of EL now seen reaching $72, according to Goldman Sachs. Estimates also upped, because of better cost controls. Neutral rating.

Humana ( HUM) target, estimate boosted at Barclays. HUM price target increased to $65 from $58. Earnings above expectations, Barclays said. 2010 EPS estimate raised to $6.50, 2011 maintained at $5.80. Reiterate Equal Weight rating.

Humana ( HUM) estimates, target upped at Goldman. HUM estimates were boosted through 2012. Company should be able to sustain some of its recent margin gains. Neutral rating and new $57 price target.

Intercontinental Exchange ( ICE) numbers increased at Goldman. ICE estimates were raised through 2012, Goldman Sachs said. Company is seeing better volume trends. Neutral rating and new $120 price target.

L-3 Communications ( LLL) price target cut at Barclays. LLL price target lowered to $92 from $100 as the company experienced organic growth slowdowns in third-quarter, Barclays said. Maintain Overweight rating.

Magellan Health ( MGLN) numbers upped at Goldman. MGLN estimates were boosted through 2012. Company is facing lower costs. Neutral rating and new $50 price target.

Nabors Industries ( NBR) cut from Conviction Buy List at Goldman. Company is approaching peak margins.

Pactiv ( PTV) estimates, target boosted at Goldman. Shares of PTV now seen reaching $33. Estimates also upped, because of better earnings momentum. Neutral rating.

Rovi ( ROVI) estimates, target raised at Goldman. Shares of ROVI now seen reaching $54. Estimates also increased, to match the company's new guidance. Neutral rating.

Torchmark ( TMK) estimates, target boosted at Goldman. Shares of TMK now seen reaching $62. Estimates also upped, given higher expected share buybacks. Neutral rating.

Under Armour ( UA) estimates increased at Morgan Stanley. UA estimates were raised through 2011. Company should improve its footwear operations. Equal-weight rating.

United Stationers ( USTR) added to Top Picks List at FBR Capital Markets. Sales should benefit from customer market share gains.

MEMC Electronic ( WFR) numbers lowered at UBS. WFR estimates were reduced through 2011, UBS said. Company is not growing its margins as quickly as expected. Buy rating and new $14.15 price target.

MEMC Electronic ( WFR) numbers upped at Goldman through 2012. Operating fundamentals are slowly improving Sell rating and new $9.50 price target.

Zimmer Holdings ( ZMH) price target cut at BofA/Merrill to $56 from $72 following disappointing third-quarter results. Maintain Buy rating.
This article was written by a staff member of TheStreet.

If you liked this article you might like

Visa, MasterCard, Discover Offer Secured Credit Cards, a Tool for College Kids

American Express Signs Deal to Reduce Financial Burden of Prepaid Cards

From Catalogs to Catastrophe: A Sears Timeline

Most Credit Card Companies Are Flying: Cramer's 'Off the Charts'

Stocks Are Fighting Back: Cramer's 'Mad Money' Recap (Wednesday 8/9/17)